Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-FR Version v5-FR
Language French French
Date Updated 2019-01-18 2019-01-18
Drug Identification Number 02297884 02297884
Brand name PRIORIX-TETRA PRIORIX-TETRA
Common or Proper name Combined measles, mumps, rubella and varicella vaccine, live, attenuated Combined measles, mumps, rubella and varicella vaccine, live, attenuated
Company Name GLAXOSMITHKLINE INC GLAXOSMITHKLINE INC
Ingredients MUMPS VIRUS VACCINE LIVE ATTENUATED VARICELLA-ZOSTER VIRUS VACCINE LIVE ATTENUATED RUBELLA VIRUS VACCINE LIVE ATTENUATED MEASLES VIRUS VACCINE LIVE ATTENUATED MUMPS VIRUS VACCINE LIVE ATTENUATED VARICELLA-ZOSTER VIRUS VACCINE LIVE ATTENUATED RUBELLA VIRUS VACCINE LIVE ATTENUATED MEASLES VIRUS VACCINE LIVE ATTENUATED
Strength(s) 25118.9UNIT 1995.2623UNIT 1000UNIT 1000UNIT 25118.9UNIT 1995.2623UNIT 1000UNIT 1000UNIT
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAMUSCULAR SUBCUTANEOUS INTRAMUSCULAR SUBCUTANEOUS
Packaging size 10's 10's
ATC code J07BD J07BD
ATC description VIRAL VACCINES VIRAL VACCINES
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2018-12-13 2018-12-13
Estimated end date 2019-02-04 2019-02-04
Actual end date 2019-01-17 2019-01-17
Shortage status Resolved Resolved
Company comments
Health Canada comments